Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare T

Charles River Laboratories advanced during the quarter following a strong earnings report and an inc

Haemonetics (HAE) might move higher on growing optimism about its earnings prospects, which is refle

The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third qua

—Expands BioCryst portfolio of targeted oral prophylactic therapy options to meet patients' individu

BBIO, NTLA, BIIB and VKTX offer investors potential upside from promising drug pipelines and upcomin

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innov

BOSTON, Oct. 19, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technolo

HAE shares surged 149.3% in a year, fueled by strong Plasma and MedSurg growth, rising product deman

Haemonetics Corporation (NYSE: HAE - Get Free Report)'s stock price hit a new 52-week high during tr

HAE's MedSurg growth and NexSys PCS adoption support its prospects, but competitive pressures and un

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform an

Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Outperform and raises the

Haemonetics (HAE) was a big mover last session on higher-than-average trading volume. The latest tre

On October 08, 2026, Haemonetics Corp (HAE) shares experienced a significant rise of 17.5%, bringing

ZUG, Switzerland, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharma

BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price targ

Gainers Pacira BioSciences (NASDAQ:PCRX) shares moved upwards by 44.0% to $36.3 during Thursday&#39

Haemonetics stock hits a new 52-week high after CSL Plasma outlines a sweeping rollout of its techno

Haemonetics (NYSE:HAE) shares jumped over 13% to $115.20 on Thursday after CSL set out a timetable f

CSL Plasma plans to use Haemonetics' plasma collection equipment across all existing U.S. centers, e

U.S. stocks fell, while Helen of Troy jumped 15.5% on strong earnings and raised guidance. Pacira so

Gainers Profound Medical (NASDAQ:PROF) shares moved upwards by 21.5% to $6.9 during Thursday's

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal H

Haemonetics (NYSE:HAE) released first-quarter financial results and hosted an earnings call on Thurs

Findings highlight opportunities for further improvement in treatment use and adherence, despite the

BOSTON, Sept. 30, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Compan

Femasys (NASDAQ: FEMY - Get Free Report) and Haemonetics (NYSE: HAE - Get Free Report) are both heal

Analysts upgraded SUNB, HAWK, and more, revising ratings and price targets.

Citigroup analyst Joanne Wuensch upgrades Haemonetics (NYSE:HAE) from Neutral to Buy and raises t

Raymond James analyst Andrew Cooper maintains Haemonetics (NYSE:HAE) with a Outperform and raises

Top Wall Street analysts changed outlook on top names. Baird raised PSN target, BTIG cut WMT target,

Baird analyst David Rescott maintains Haemonetics (NYSE:HAE) with a Outperform and raises the pri

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform an

Shares of Haemonetics Corp (NYSE: HAE) are trading higher Tuesday afternoon following news of a sign

US stocks down, Nasdaq falls 300+ points. Duos Tech shares rise on better Q2 results. Many other bi

BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price targ

Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday'

Haemonetics anticipates CSL to transition a portion of its U.S. plasma collection centers to the Com

Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the p

JP Morgan analyst Allen Gong maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price

BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price targ

Haemonetics (NYSE:HAE) widens FY2027 sales outlook from $1.410 billion-$1.427 billion to $1.401 bill

Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Outperform and raises the

Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Outperform and raises the

Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the p

Analysts upgraded HAE, VIK, and TXN, and raised price targets. Check out other analysts' views o

B of A Securities analyst Craig Bijou upgrades Haemonetics (NYSE:HAE) from Neutral to Buy and rai

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform an